
Therapeutic options in refractory anti-MDA5 dermatomyositis triggered by SARS-CoV-2 infection
Author(s) -
Elena Jugănaru,
Alexandra Constantinescu,
Claudia-Oana Cobilinschi,
C Constantinescu
Publication year - 2022
Publication title -
romanian journal of rheumatology
Language(s) - English
Resource type - Journals
eISSN - 2069-6086
pISSN - 1843-0791
DOI - 10.37897/rjr.2022.3.6
Subject(s) - medicine , hydroxychloroquine , dermatomyositis , rituximab , dermatology , interstitial lung disease , tacrolimus , rheumatoid arthritis , antisynthetase syndrome , disease , autoimmunity , tocilizumab , immunology , lung , covid-19 , lymphoma , infectious disease (medical specialty) , transplantation